Desikan, M;
Scalco, RS;
Manole, A;
Gardiner, A;
schapira, A;
Lachmann, R;
Houlden, H;
... Quinlivan, R; + view all
(2018)
GYG1 causing progressive limb girdle myopathy with onset during teenage years (polyglucosan body myopathy 2).
Neuromuscular Disorders
, 28
(4)
pp. 346-349.
10.1016/j.nmd.2018.01.002.
Preview |
Text
Desikan et al, GYG1.pdf - Accepted Version Download (466kB) | Preview |
Abstract
An 84-year-old lady with slowly progressive limb and axial muscle weakness with onset in her teens was referred for genetic investigations. Targeted next generation sequencing (NGS) revealed a homozygous mutation GYG1 in exon5:c.487delG:p.D163fs, confirming the diagnosis of Polyglucosan Body Myopathy 2 (PGBM2). Retrospective review of muscle pathology revealed a florid vacuolar myopathy with histochemical and ultrastructural features consistent with a polyglucosan storage myopathy. No cardiac symptoms were reported. Our case is consistent with the core phenotype of GYG1-related PGBM2 apart from an early onset of weakness without cardiac symptoms. The presence of α-amylase resistant PAS-positive material in skeletal muscle biopsy of patients with slowly progressive limb girdle muscle weakness should prompt the search for GYG1 mutations. This case highlights the combined role of muscle pathology and NGS in the molecular resolution of undiagnosed patients with undiagnosed neuromuscular conditions.
Archive Staff Only
 |
View Item |
